Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr 27;16(5):652.
doi: 10.3390/ph16050652.

Special Issue "Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022"

Barbara Ruaro  1 , Murray Baron  2 , Edoardo Rosato  3 , Romeo Martini  4 , Marco Confalonieri  1
Affiliations
Editorial

Special Issue "Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022"

Barbara Ruaro et al. Pharmaceuticals (Basel). .

Abstract

This Special Issue, titled "Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations", aims to demonstrate recent and new advances and future trends in the field of rheumatic diseases [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ruaro B., Confalonieri M., Matucci-Cerinic M., Salton F., Confalonieri P., Santagiuliana M., Citton G.M., Baratella E., Bruni C. The Treatment of Lung Involvement in Systemic Sclerosis. Pharmaceuticals. 2021;14:154. doi: 10.3390/ph14020154. - DOI - PMC - PubMed
    1. Bernero E., Sulli A., Ferrari G., Ravera F., Pizzorni C., Ruaro B., Zampogna G., Alessandri E., Cutolo M. Prospective capillaroscopy-based study on transition from primary to secondary Raynaud’s phenomenon: Preliminary results. Reumatismo. 2013;65:186–191. doi: 10.4081/reumatismo.2013.186. - DOI - PubMed
    1. Ruaro B., Soldano S., Smith V., Paolino S., Contini P., Montagna P., Pizzorni C., Casabella A., Tardito S., Sulli A., et al. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: A pilot study. Rheumatol. Int. 2019;39:1369–1376. doi: 10.1007/s00296-019-04315-7. - DOI - PubMed
    1. Ruaro B., Gandin I., Pozzan R., Tavano S., Bozzi C., Hughes M., Kodric M., Cifaldi R., Lerda S., Confalonieri M., et al. Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy. Pharmaceuticals. 2023;16:307. doi: 10.3390/ph16020307. - DOI - PMC - PubMed
    1. Salem H.F., Abd El-Maboud M.M., Said A.S.A., Salem M.N., Sabry D., Hussain N., El-Ghafar O.A.M.A., Hussein R.R.S. Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals. 2023;16:60. doi: 10.3390/ph16010060. - DOI - PMC - PubMed

Publication types

LinkOut - more resources